Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP922539.RAu28n_GxC328e2tqTOHQfJBdo9mnmiggfJX3JKrMuHd0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP922539.RAu28n_GxC328e2tqTOHQfJBdo9mnmiggfJX3JKrMuHd0130_assertion type Assertion NP922539.RAu28n_GxC328e2tqTOHQfJBdo9mnmiggfJX3JKrMuHd0130_head.
- NP922539.RAu28n_GxC328e2tqTOHQfJBdo9mnmiggfJX3JKrMuHd0130_assertion description "[We have employed chimeric antisense oligonucleotides to investigate the molecular alterations after targeted interference with Plk1 in RKO human colon adenocarcinoma and PC3 prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP922539.RAu28n_GxC328e2tqTOHQfJBdo9mnmiggfJX3JKrMuHd0130_provenance.
- NP922539.RAu28n_GxC328e2tqTOHQfJBdo9mnmiggfJX3JKrMuHd0130_assertion evidence source_evidence_literature NP922539.RAu28n_GxC328e2tqTOHQfJBdo9mnmiggfJX3JKrMuHd0130_provenance.
- NP922539.RAu28n_GxC328e2tqTOHQfJBdo9mnmiggfJX3JKrMuHd0130_assertion SIO_000772 16648550 NP922539.RAu28n_GxC328e2tqTOHQfJBdo9mnmiggfJX3JKrMuHd0130_provenance.
- NP922539.RAu28n_GxC328e2tqTOHQfJBdo9mnmiggfJX3JKrMuHd0130_assertion wasDerivedFrom befree-20140225 NP922539.RAu28n_GxC328e2tqTOHQfJBdo9mnmiggfJX3JKrMuHd0130_provenance.
- NP922539.RAu28n_GxC328e2tqTOHQfJBdo9mnmiggfJX3JKrMuHd0130_assertion wasGeneratedBy ECO_0000203 NP922539.RAu28n_GxC328e2tqTOHQfJBdo9mnmiggfJX3JKrMuHd0130_provenance.